3 doctors weighed in:

What are the current targeted gene therapies for synovial sarcoma? How effective are they?

3 doctors weighed in
Dr. Ed Friedlander
Pathology
1 doctor agrees

In brief: Very early

Nothing is standard.
Phone the folks at the National Cancer Institute and see if you can get into a study. Even if it does not help, you have advanced scientific knowledge for the next person.

In brief: Very early

Nothing is standard.
Phone the folks at the National Cancer Institute and see if you can get into a study. Even if it does not help, you have advanced scientific knowledge for the next person.
Dr. Ed Friedlander
Dr. Ed Friedlander
Thank
Dr. Jonathan Trent
Internal Medicine - Oncology

In brief: Pazopanib

Combination chemotherapy with doxorubicin and ifosfamide is standard and efficacious.
We use pazopanib in second line to target VEGFR, FGFR, PDGFR, and other proteins. Also many targeted immunotherapies are in trials: https://clinicaltrials.sylvester.org

In brief: Pazopanib

Combination chemotherapy with doxorubicin and ifosfamide is standard and efficacious.
We use pazopanib in second line to target VEGFR, FGFR, PDGFR, and other proteins. Also many targeted immunotherapies are in trials: https://clinicaltrials.sylvester.org
Dr. Jonathan Trent
Dr. Jonathan Trent
Thank
Read more answers from doctors